Opens in a new tab
  • |
    01.11.2026

    CIPM 2026 | Tailin Showcases Biopharma Solutions and Celebrates 25 Years of Isolator Innovation

    CIPM 2026

    From October 27 to 29, 2026, the 68th China International Pharmaceutical Machinery Exposition (CIPM) grandly opened at the Xiamen International Expo Center. As a leading domestic innovator in pharmaceutical equipment, Zhejiang Tailin Scitech Co., LTD presented its comprehensive product portfolio covering aseptic production and quality control, pharmaceutical microbiology testing, and precision analytical detection. Tailin engaged in in-depth exchanges with global industry experts, clients, and partners on cutting-edge topics such as sterile manufacturing, laboratory digital intelligence, cell therapy, and equipment upgrades.


    Comprehensive Matrix: Tailin’s Innovative Solutions Address Industry Demands

    At the exhibition, Tailin showcased its full-series equipment lineup, including sterility test isolator, aseptic filling isolator, VHP generator, automated sterility test systems, microbial limit tester, rapid microbial detection analyzer, and Total Organic Carbon (TOC) analyzer, alongside supporting consumables like microporous membrane filters and biological indicators. Covering the entire lifecycle from environmental decontamination and aseptic isolation to rapid microbial screening, package integrity testing, and water quality monitoring, Tailin delivered an integrated “Instruments + Consumables + Application Solutions” matrix to support full-process quality control.


    Frontline Dialogue: Exploring New Paths for CGT Aseptic Assurance

    During the event, Tailin’s Chief Expert in Cell and Gene Therapy (CGT), Sun Weiqun, delivered a keynote presentation titled “Application and Practice of Cell Preparation Isolators in the Full Process of Cell Therapy.” Addressing pain points such as the inability to terminal-sterilize cell products and multiple contamination risk nodes, he introduced Tailin’s combined solution of cell drug preparation workstations and honeycomb culture systems, highlighting key technologies like closed operation, biological decontamination, and data traceability to help advance the implementation of CGT aseptic assurance.


    25 Years of Growth: From Filling Voids to Industry Leadership

    This year’s Xiamen exhibition coincided with the 25th anniversary of Tailin’s independent R&D in isolator technology. Since introducing China’s first aseptic isolator in 2001, Tailin has continuously pioneered domestic breakthroughs—including the first negative-pressure isolator, closed cell preparation workstations, and the latest CST-series aseptic isolators—expanding into laboratory animal isolation and radiopharmaceutical production. The featured CST-LG4 sterility test isolator and aseptic filling isolator at the booth epitomize Tailin’s 25 years of technological accumulation and iterative innovation.

    Over the past quarter-century, Tailin has expanded its portfolio across diverse applications while staying true to its core mission: safeguarding sterility, driving independent technological innovation, and remaining dedicated to customer needs. Tailin looks forward to continuously empowering the high-quality development of the global pharmaceutical industry.

    More Info: CIPM Xiamen 2026 | Youtube